OXFORD, England, October 31, 2011 /PRNewswire/ --
- Research and development agreement signed with Mayo Clinic -
Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that it has entered into a...